CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12,539 enrolled
Drug / intervention
Emergency, or elective gastrointestinal resectionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02662231
NCT02662231N/ACompleted

Determining the Worldwide Epidemiology of Surgical Site Infections After Gastrointestinal Surgery

University of Edinburgh·observational·Posted Jan 25, 2016·Updated May 22, 2024

In Brief

An observational study evaluating Emergency, or elective gastrointestinal resection for Surgical Wound Infection. Completed, enrolled 12,539 participants across 2 sites.

Detailed Summary

Surgical site infection (SSI) is the most common complication following major gastrointestinal surgery, affecting between 25-40% of patients. The rate of SSI doubles from low-income to high-income settings, persisting after risk adjustment. Investigating the diagnosis and treatment of SSIs remains a largely unaddressed global health priority. The impact of antibiotic resistant organisms and the effectiveness of antibiotic prophylaxis are unknown. This study aims to determine SSI rates following gastrointestinal surgery across worldwide hospital settings.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 25, 2016
Enrollment StartJan 1, 2016
Primary CompletionJul 31, 2016
Study CompletionSep 30, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.4 years ago

Interventions

Emergency, or elective gastrointestinal resectionprocedure

Gastrointestinal resection is defined as complete transection and removal of a segment of the oesophagus, stomach, small bowel, colon or rectum, including cholecystectomy, and appendicectomy.